321 related articles for article (PubMed ID: 34648805)
1. The potential of cannabinoids and inhibitors of endocannabinoid degradation in respiratory diseases.
Kicman A; Pędzińska-Betiuk A; Kozłowska H
Eur J Pharmacol; 2021 Nov; 911():174560. PubMed ID: 34648805
[TBL] [Abstract][Full Text] [Related]
2. Endocannabinoid System in the Airways.
Bozkurt TE
Molecules; 2019 Dec; 24(24):. PubMed ID: 31861200
[TBL] [Abstract][Full Text] [Related]
3. [The role of endocannabinoid system in physiological and pathological processes in the eye].
Nadolska K; Goś R
Klin Oczna; 2008; 110(10-12):392-6. PubMed ID: 19195174
[TBL] [Abstract][Full Text] [Related]
4. The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.
Murillo-Rodriguez E; Pastrana-Trejo JC; Salas-Crisóstomo M; de-la-Cruz M
CNS Neurol Disord Drug Targets; 2017; 16(4):370-379. PubMed ID: 28240187
[TBL] [Abstract][Full Text] [Related]
5. Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels.
De Petrocellis L; Di Marzo V
J Neuroimmune Pharmacol; 2010 Mar; 5(1):103-21. PubMed ID: 19847654
[TBL] [Abstract][Full Text] [Related]
6. The Effects of Endogenous Cannabinoids on the Mammalian Respiratory System: A Scoping Review of Cyclooxygenase-Dependent Pathways.
Kolousek A; Pak-Harvey E; Liu-Lam O; White M; Smith P; Henning F; Koval M; Levy JM
Cannabis Cannabinoid Res; 2023 Jun; 8(3):434-444. PubMed ID: 37074668
[No Abstract] [Full Text] [Related]
7. Medical Use of Cannabinoids.
Fraguas-Sánchez AI; Torres-Suárez AI
Drugs; 2018 Nov; 78(16):1665-1703. PubMed ID: 30374797
[TBL] [Abstract][Full Text] [Related]
8. Novel approaches and current challenges with targeting the endocannabinoid system.
Morales P; Jagerovic N
Expert Opin Drug Discov; 2020 Aug; 15(8):917-930. PubMed ID: 32336154
[TBL] [Abstract][Full Text] [Related]
9. Endocannabinoid System: A Multi-Facet Therapeutic Target.
Kaur R; Ambwani SR; Singh S
Curr Clin Pharmacol; 2016; 11(2):110-7. PubMed ID: 27086601
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Use of Synthetic Cannabinoids: Still an OpenIssue?
De Luca MA; Fattore L
Clin Ther; 2018 Sep; 40(9):1457-1466. PubMed ID: 30180974
[TBL] [Abstract][Full Text] [Related]
11. Endocannabinoid system and mood disorders: priming a target for new therapies.
Micale V; Di Marzo V; Sulcova A; Wotjak CT; Drago F
Pharmacol Ther; 2013 Apr; 138(1):18-37. PubMed ID: 23261685
[TBL] [Abstract][Full Text] [Related]
12. The evolution of cannabinoid receptors in cancer.
Pennant NM; Hinton CV
WIREs Mech Dis; 2023; 15(4):e1602. PubMed ID: 36750231
[TBL] [Abstract][Full Text] [Related]
13. Role of lipids and lipid signaling in the development of cannabinoid tolerance.
Martin BR
Life Sci; 2005 Aug; 77(14):1543-58. PubMed ID: 15949820
[TBL] [Abstract][Full Text] [Related]
14. The endogenous cardiac cannabinoid system: a new protective mechanism against myocardial ischemia.
Lamontagne D; Lépicier P; Lagneux C; Bouchard JF
Arch Mal Coeur Vaiss; 2006 Mar; 99(3):242-6. PubMed ID: 16618028
[TBL] [Abstract][Full Text] [Related]
15. Beyond THC and Endocannabinoids.
Pacher P; Kogan NM; Mechoulam R
Annu Rev Pharmacol Toxicol; 2020 Jan; 60():637-659. PubMed ID: 31580774
[TBL] [Abstract][Full Text] [Related]
16. Endocannabinoids in the gastrointestinal tract.
Lee Y; Jo J; Chung HY; Pothoulakis C; Im E
Am J Physiol Gastrointest Liver Physiol; 2016 Oct; 311(4):G655-G666. PubMed ID: 27538961
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoids as Anticancer Drugs.
Ramer R; Hinz B
Adv Pharmacol; 2017; 80():397-436. PubMed ID: 28826542
[TBL] [Abstract][Full Text] [Related]
18. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
[TBL] [Abstract][Full Text] [Related]
19. Unveiling the angiogenic effects of cannabinoids: Enhancers or inhibitors?
Maia J; Fonseca BM; Teixeira N; Correia-da-Silva G
Biochem Pharmacol; 2023 Sep; 215():115686. PubMed ID: 37463627
[TBL] [Abstract][Full Text] [Related]
20. The role of cannabinoids in inflammatory modulation of allergic respiratory disorders, inflammatory pain and ischemic stroke.
Pini A; Mannaioni G; Pellegrini-Giampietro D; Passani MB; Mastroianni R; Bani D; Masini E
Curr Drug Targets; 2012 Jun; 13(7):984-93. PubMed ID: 22420307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]